Kevin C. Nixon

Agricultural and Biological Sciences · Life Sciences

52h-index18.4kcitations165works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Plant Diversity and Evolution(72), Plant and animal studies(49), Plant and Fungal Species Descriptions(39), Evolution and Paleontology Studies(17), Lung Cancer Research Studies(14)

Publications165 total

Data from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Table S3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Methods from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Figure 4 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Figure 2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Table S2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Figure 1 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Table S1 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
Supplementary Figure 3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026Open Access
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
npj Breast Cancer·2025Open Access
CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
Molecular Cancer Therapeutics·2025Open Access
PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents
Neoplasia·2025· 2 citedOpen Access
Abstract 3997: Advancing precision cancer medicine with patient-derived organoids: an endometrial cancer case study
Cancer Research·2025
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
Nature Communications·2024· 11 citedOpen Access
CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer
International Journal of Radiation Oncology*Biology*Physics·2023· 6 cited
Insulin receptor loss impairs mammary tumorigenesis in mice
Cell Reports·2023· 1 citedOpen Access
RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells
Nucleic Acids Research·2023· 22 citedOpen Access
Supplementary Data from Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
2023Open Access
Supplementary Data from Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
2023Open Access
Supplementary Data from Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

William L. Crepet(20), María A. Gandolfo(10), James M. Carpenter(6), Quentin D. Wheeler(3), Jerrold I. Davis(3), Else Marie Friis(3), Pablo A. Goloboff(2), James S. Farris(2), Mark W. Chase(2), Paul S. Manos(2), Jeff J. Doyle(2), Dennis W. Stevenson(2), Elizabeth J. Hermsen(2), Peter Wilf(2), N. Rubén Cúneo(2), Patrick S. Herendeen(2), Douglas E. Soltis(1), Pamela S. Soltis(1), Mark E. Mort(1), Dirk C. Albach(1)